MYRIAD GENETICS, INC. Proceeds from (Payments for) Other Financing Activities
MYRIAD GENETICS, INC. (MYGN) reported Proceeds from (Payments for) Other Financing Activities of -$200.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-02-24
- MYRIAD GENETICS, INC. proceeds from (payments for) other financing activities for fiscal 2025 was -$200.00K.
- MYRIAD GENETICS, INC. proceeds from (payments for) other financing activities for fiscal 2024 was -$400.00K.
- MYRIAD GENETICS, INC. proceeds from (payments for) other financing activities for fiscal 2023 was -$200.00K.
| Period end | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|
| 2025-12-31 | -$200.00K 10-K · filed 2026-02-24 |
| 2024-12-31 | -$400.00K 10-K · filed 2026-02-24 |
| 2023-12-31 | -$200.00K 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |